Health
CEBINA reports positive findings on the potency of azelastine, a widely used anti-histamine, as anti-COVID-19 approach – PRNewswire
/PRNewswire/ — CEBINA GmbH, an Austrian biotech company, today announces further positive results in its collaborative COVID-19 drug repurposing project,…
VIENNA, Sept. 17, 2020 /PRNewswire/ — CEBINA GmbH, an Austrian biotech company, today announces further positive results in its collaborative COVID-19 drug repurposing project, demonstrating that a common allergy nasal spray medication containing azelastine has potent efficacy against SARS-CoV-2 in a human 3D nasal tissue model.
Azelastine, a generic anti-histamine medication, has previously been identified as a potential anti-COVID-19 drug by CEBINA in collaboration with Professor Robert Konr…
-
Noosa News24 hours agoState clears the way for farmland on Brisbane fringe to be developed
-
General18 hours agoPrada to buy rival Versace in $2.3 billion deal
-
Noosa News24 hours agoWho won the first debate? Take the Brisbane Times Quiz
-
General17 hours agoUS considering tariff deals with 15 countries: official